Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 16Neoplasms 4Colorectal Neoplasms 3Adenocarcinoma 3Pancreatic Cancer Metastatic 2Neoplasm Metastasis 2Pancreatic Cancer Non-resectable 1Diabetes Mellitus, Insulin-Dependent, 12 1Cholangiocarcinoma 1Carcinoma 1

Interventions

Fluorouracil 255Leucovorin 224Oxaliplatin 218Irinotecan 206Bevacizumab 200Capecitabine 144Cetuximab 136Panitumumab 68Folfox protocol 63regorafenib 50Colonoscopy 44pembrolizumab 42IFL protocol 39Radiotherapy 32Nivolumab 31Drug Therapy 27trifluridine tipiracil drug combination 26Gemcitabine 24Blood Specimen Collection 23Chemotherapy, Adjuvant 20Surveys and Questionnaires 19Celecoxib 19Surgical Procedures, Operative 16durvalumab 15Neoadjuvant Therapy 15Cyclophosphamide 14Cisplatin 14aflibercept 13Standard of Care 13Pemetrexed 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Colorectal Neoplasms × folfirinox × Clear all
NCT03828799 2026-02-27

FOLFIRINOX-R

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed
13 enrolled 22 charts
Gastrointestinal

Colorectal Neoplasms

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03914170 2023-09-26

ESTER

Institut du Cancer de Montpellier - Val d'Aurelle

Completed
70 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡